Alendronic acid

Also known as: Alendronate sodium

Therapeutic indications

Alendronic acid is indicated for:

Population group: both men and women, only adults (18 years old or older)

Alendronic acid is indicated for the treatment of:

osteoporosis in post-menopausal women to prevent fractures
osteoporosis in men to prevent fractures
glucocorticoid-induced osteoporosis and prevention of bone loss in post-menopausal women considered at risk of developing the disease

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Alendronic acid is contraindicated in the following cases:

Hypocalcemia

at least one of

Stricture of esophagus

Achalasia of esophagus

Unable to stand up

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Lactation